메뉴 건너뛰기




Volumn 34, Issue 45, 2013, Pages

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease

(28)  Nordestgaard, Børge G a   Chapman, M John b   Humphries, Steve E c   Ginsberg, Henry N d   Masana, Luis e   Descamps, Olivier S f   Wiklund, Olov g   Hegele, Robert A h   Raal, Frederick J i   Defesche, Joep C j   Wiegman, Albert j   Santos, Raul D k   Watts, Gerald F l   Parhofer, Klaus G m   Hovingh, G Kees j   Kovanen, Petri T n   Boileau, Catherine o   Averna, Maurizio p   Borén, Jan q   Bruckert, Eric b   more..


Author keywords

Atherosclerosis; Cardiovascular disease; Cholesterol; Coronary heart disease; Low density lipoprotein

Indexed keywords

CHOLESTEROL; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

EID: 84890461947     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht273     Document Type: Article
Times cited : (2194)

References (56)
  • 1
    • 0000600880 scopus 로고    scopus 로고
    • Familial hypercholesterolemia
    • In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) 8th ed. New York: McGraw-Hill;
    • Goldstein JK, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds), The Metabolic & Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001. p. 2863-2913.
    • (2001) The Metabolic & Molecular Bases of Inherited Disease , pp. 2863-2913
    • Goldstein, J.K.1    Hobbs, H.H.2    Brown, M.S.3
  • 2
    • 4444376916 scopus 로고    scopus 로고
    • Genetic causes of monogenic heterozygous familial hypercholesterolemia: A huge prevalence review
    • Austin MA, Hutter CM, Zimmern RL, Humphries SE. Genetic causes of monogenic heterozygous familial hypercholesterolemia: A HuGE prevalence review. Am J Epidemiol 2004;160:407-420.
    • (2004) Am J Epidemiol , vol.160 , pp. 407-420
    • Austin, M.A.1    Hutter, C.M.2    Zimmern, R.L.3    Humphries, S.E.4
  • 4
    • 0037541585 scopus 로고    scopus 로고
    • A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia
    • Marks D, Thorogood M, Neil HA, Humphries SE. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis 2003;168: 1-14.
    • (2003) Atherosclerosis , vol.168 , pp. 1-14
    • Marks, D.1    Thorogood, M.2    Neil, H.A.3    Humphries, S.E.4
  • 5
    • 0003661906 scopus 로고    scopus 로고
    • World Health Organization. Internet. 9 October
    • World Health Organization. World Healths Statistics 2012. Internet. http://www.who.int/gho/publications/world-health-statistics/2012/en/(9 October 2012).
    • (2012) World Healths Statistics 2012
  • 9
    • 0017276019 scopus 로고
    • The inheritance of hyperlipoproteinaemia with xanthomatosis. A study of 132 kindreds
    • Heiberg A, Berg K. The inheritance of hyperlipoproteinaemia with xanthomatosis.A study of 132 kindreds. Clin Genet 1976;9:203-233.
    • (1976) Clin Genet , vol.9 , pp. 203-233
    • Heiberg, A.1    Berg, K.2
  • 10
    • 84868628467 scopus 로고    scopus 로고
    • Familial hypercholesterolemia in the danish general population: Prevalence, coronary artery disease, and cholesterol-lowering medication
    • Benn M,Watts GF, Tybjaerg-Hansen A, Nordestgaard BG. Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab 2012;97:3956-3964.
    • (2012) J Clin Endocrinol Metab , vol.97 , pp. 3956-3964
    • Benn, M.1    Watts, G.F.2    Tybjaerg-Hansen, A.3    Nordestgaard, B.G.4
  • 11
    • 0034662322 scopus 로고    scopus 로고
    • Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: Prospective registry study
    • Neil HA, Hammond T, Huxley R, MatthewsDR, Humphries SE. Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study. BMJ 2000;321:148.
    • (2000) BMJ , vol.321 , pp. 148
    • Neil, H.A.1    Hammond, T.2    Huxley, R.3    Matthews, D.R.4    Humphries, S.E.5
  • 12
    • 0032890205 scopus 로고    scopus 로고
    • Mortality in treated heterozygous familial hypercholesterolaemia: Implications for clinical management
    • Scientific Steering Committee on behalf of the Simon Broome Register Group
    • Scientific Steering Committee on behalf of the Simon Broome Register Group. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Atherosclerosis 1999;142:105-112.
    • (1999) Atherosclerosis , vol.142 , pp. 105-112
  • 14
    • 0041743167 scopus 로고    scopus 로고
    • Monogenic hypercholesterolemia: New insights in pathogenesis and treatment
    • Rader DJ, Cohen J, Hobbs HH. Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest 2003;111:1795-1803.
    • (2003) J Clin Invest , vol.111 , pp. 1795-1803
    • Rader, D.J.1    Cohen, J.2    Hobbs, H.H.3
  • 16
    • 84864772507 scopus 로고    scopus 로고
    • Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment
    • Raal FJ, Santos RD. Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment. Atherosclerosis 2012;223:262-268.
    • (2012) Atherosclerosis , vol.223 , pp. 262-268
    • Raal, F.J.1    Santos, R.D.2
  • 19
    • 0037326907 scopus 로고    scopus 로고
    • Systematic family screening for familial hypercholesterolemia in iceland
    • Thorsson B, Sigurdsson G, Gudnason V. Systematic family screening for familial hypercholesterolemia in Iceland. Arterioscler Thromb Vasc Biol 2003;23:335-338.
    • (2003) Arterioscler Thromb Vasc Biol , vol.23 , pp. 335-338
    • Thorsson, B.1    Sigurdsson, G.2    Gudnason, V.3
  • 20
    • 84864579096 scopus 로고    scopus 로고
    • Discriminative ability of ldl-cholesterol to identify patients with familial hypercholesterolemia: A crosssectional study in 26,406 individuals tested for genetic fh
    • Huijgen R, Hutten BA, Kindt I, Vissers MN, Kastelein JJ. Discriminative ability of LDL-cholesterol to identify patients with familial hypercholesterolemia: A crosssectional study in 26,406 individuals tested for genetic FH. Circ Cardiovasc Genet 2012;5:354-359.
    • (2012) Circ Cardiovasc Genet , vol.5 , pp. 354-359
    • Huijgen, R.1    Hutten, B.A.2    Kindt, I.3    Vissers, M.N.4    Kastelein, J.J.5
  • 21
    • 44949145140 scopus 로고    scopus 로고
    • Development of sensitive and specific age-And gender-specific lowdensity lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing
    • Starr B, Hadfield SG, Hutten BA, Lansberg PJ, Leren TP, Damgaard D, Neil HA, Humphries SE. Development of sensitive and specific age-And gender-specific lowdensity lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing. Clin Chem Lab Med 2008;46: 791-803.
    • (2008) Clin Chem Lab Med , vol.46 , pp. 791-803
    • Starr, B.1    Hadfield, S.G.2    Hutten, B.A.3    Lansberg, P.J.4    Leren, T.P.5    Damgaard, D.6    Neil, H.A.7    Humphries, S.E.8
  • 22
    • 10744233618 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia
    • Civeira F. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis 2004;173:55-68.
    • (2004) Atherosclerosis , vol.173 , pp. 55-68
    • Civeira, F.1
  • 29
    • 67049167090 scopus 로고    scopus 로고
    • Genetically elevated lipoprotein(a) and increased risk of myocardial infarction
    • Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009;301: 2331-2339.
    • (2009) JAMA , vol.301 , pp. 2331-2339
    • Kamstrup, P.R.1    Tybjaerg-Hansen, A.2    Steffensen, R.3    Nordestgaard, B.G.4
  • 32
    • 84875794360 scopus 로고    scopus 로고
    • Treatment of severe genetic dyslipidemia: Where are we going?
    • Stefanutti C. Treatment of severe genetic dyslipidemia: where are we going?. Ther Apher Dial 2013;17:122-123.
    • (2013) Ther Apher Dial , vol.17 , pp. 122-123
    • Stefanutti, C.1
  • 33
    • 84875812131 scopus 로고    scopus 로고
    • Italian multicenter study on low-density lipoprotein apheresisworking group 2009 survey
    • Stefanutti C, Morozzi C, Di GS. Italian multicenter study on low-density lipoprotein apheresisWorking Group 2009 survey. Ther Apher Dial 2013;17:169-178.
    • (2013) Ther Apher Dial , vol.17 , pp. 169-178
    • Stefanutti, C.1    Morozzi, C.2    Di, G.S.3
  • 38
    • 0031439541 scopus 로고    scopus 로고
    • Neonatal diagnosis of familial hypercholesterolemia in newborns born to a parent with a molecularly defined heterozygous familial hypercholesterolemia
    • Vuorio AF, Turtola H, Kontula K. Neonatal diagnosis of familial hypercholesterolemia in newborns born to a parent with a molecularly defined heterozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 1997;17:3332-3337.
    • (1997) Arterioscler Thromb Vasc Biol , vol.17 , pp. 3332-3337
    • Vuorio, A.F.1    Turtola, H.2    Kontula, K.3
  • 39
    • 67349130249 scopus 로고    scopus 로고
    • Genetic testing in asymptomatic minors: Recommendations of the european society of human genetics
    • Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics. Eur J Hum Genet 2009;17:720-721.
    • (2009) Eur J Hum Genet , vol.17 , pp. 720-721
  • 40
    • 66349126280 scopus 로고    scopus 로고
    • Pcsk9: A convertase that coordinates ldl catabolism
    • Horton JD, Cohen JC, Hobbs HH. PCSK9: A convertase that coordinates LDL catabolism. J Lipid Res 2009;50(Suppl):S172-S177.
    • (2009) J Lipid Res , vol.50 , Issue.SUPPL.
    • Horton, J.D.1    Cohen, J.C.2    Hobbs, H.H.3
  • 41
    • 84860821853 scopus 로고    scopus 로고
    • Is the process of delivery of an individually tailored lifestyle intervention associated with improvements in ldl cholesterol and multiple lifestyle behaviours in people with familial hypercholesterolemiä
    • Broekhuizen K, Jelsma GJ, van PoppelNM, Koppes LL, Brug J, vanMW. Is the process of delivery of an individually tailored lifestyle intervention associated with improvements in LDL cholesterol and multiple lifestyle behaviours in people with Familial Hypercholesterolemiä BMC Public Health 2012;12:348.
    • (2012) BMC Public Health , vol.12 , pp. 348
    • Broekhuizen, K.1    Jelsma, G.J.2    Van, PoppelN.M.3    Koppes, L.L.4    Brug, J.5    Van, M.W.6
  • 42
    • 0024522835 scopus 로고
    • Low-dose colestipol plus fenofibrate: Effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia
    • Weisweiler P. Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia. Metabolism 1989;38:271-274.
    • (1989) Metabolism , vol.38 , pp. 271-274
    • Weisweiler, P.1
  • 43
    • 79956288028 scopus 로고    scopus 로고
    • Treatment of adults with familial hypercholesterolemia and evidence for treatment: Recommendations from the national lipid association expert panel on familial hypercholesterolemia
    • Robinson JG, Goldberg AC. Treatment of adults with familial hypercholesterolemia and evidence for treatment: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 2011;5:S18-S29.
    • (2011) J Clin Lipidol , vol.5
    • Robinson, J.G.1    Goldberg, A.C.2
  • 45
    • 77957354333 scopus 로고    scopus 로고
    • Lowdensity lipoprotein apheresis using double filtration plasmapheresis: 27-month use in a child with homozygous familial hypercholesterolemia
    • Fernandez-Fuertes LF, Tapia MM, Nieves PI, Novoa Mogollon FJ, Diaz CJ. Lowdensity lipoprotein apheresis using double filtration plasmapheresis: 27-month use in a child with homozygous familial hypercholesterolemia. Ther Apher Dial 2010;14:484-485.
    • (2010) Ther Apher Dial , vol.14 , pp. 484-485
    • Fernandez-Fuertes, L.F.1    Tapia, M.M.2    Nieves, P.I.3    Novoa Mogollon, F.J.4    Diaz, C.J.5
  • 50
    • 36148976818 scopus 로고    scopus 로고
    • Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: A systematic review and meta-Analysis
    • Arambepola C, Farmer AJ, Perera R, Neil HA. Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: A systematic review and meta-Analysis. Atherosclerosis 2007;195:339-347.
    • (2007) Atherosclerosis , vol.195 , pp. 339-347
    • Arambepola, C.1    Farmer, A.J.2    Perera, R.3    Neil, H.A.4
  • 53
    • 0036607353 scopus 로고    scopus 로고
    • Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia
    • Marks D,Wonderling D, Thorogood M, Lambert H, Humphries SE, Neil HA. Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia. BMJ 2002;324:1303.
    • (2002) BMJ , vol.324 , pp. 1303
    • Marks, D.1    Wonderling, D.2    Thorogood, M.3    Lambert, H.4    Humphries, S.E.5    Neil, H.A.6
  • 54
    • 74549114679 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of the use of a high-intensity statin compared to a low-intensity statin in the management of patients with familial hypercholesterolaemia
    • Nherera L, Calvert NW, Demott K, Humphries SE, Neil HA, Minhas R, Thorogood M. Cost-effectiveness analysis of the use of a high-intensity statin compared to a low-intensity statin in the management of patients with familial hypercholesterolaemia. Curr Med Res Opin 2010;26:529-536.
    • (2010) Curr Med Res Opin , vol.26 , pp. 529-536
    • Nherera, L.1    Calvert, N.W.2    Demott, K.3    Humphries, S.E.4    Neil, H.A.5    Minhas, R.6    Thorogood, M.7
  • 55
    • 79959347897 scopus 로고    scopus 로고
    • Probabilistic costeffectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies
    • Nherera L, Marks D, Minhas R, Thorogood M, Humphries SE. Probabilistic costeffectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies. Heart 2011;97:1175-1181.
    • (2011) Heart , vol.97 , pp. 1175-1181
    • Nherera, L.1    Marks, D.2    Minhas, R.3    Thorogood, M.4    Humphries, S.E.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.